Fulcrum Therapeutics
Utility Patent Applications
Last updated:
List of all Fulcrum Therapeutics patents 6 in total
| Status | Patent |
|---|---|
Application | Utility: MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS Filling date: 8 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD Filling date: 8 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR INCREASING FETAL HEMOGLOBIN AND TREATING SICKLE CELL DISEASE Filling date: 8 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD Filling date: 8 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS Filling date: 8 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: USE OF P38 INHIBITORS TO REDUCE EXPRESSION OF DUX4 Filling date: 8 Sep 2025 Issue date: 22 Oct 2020 |
Showing 1 to 6 of 6 patents.